A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension
Clinical trial NCT00779181 · COMPLETED
Trial details
- NCT number
- NCT00779181
- Sponsor
- Addrenex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2008-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.